-+ 0.00%
-+ 0.00%
-+ 0.00%

PALISADE BIO, INC. ANNOUNCES RECEIPT OF CASH PROCEEDS FROM CANADA’S SR&ED TAX INCENTIVE PROGRAM FOR REIMBURSEMENT OF DEVELOPMENT COSTS OF PALI-2108 FOR TREATMENT OF ULCERATIVE COLITIS (UC)

Reuters·02/20/2025 13:45:00

Please log in to view news